Global Blood Collection Robots Market Research Report 2026

Blood Collection Robots Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood Collection Robots competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Blood collection robots are medical robot systems designed for hospital blood collection windows, physical examination centers, and medical laboratory pre-processing scenarios. Their core capabilities include using near-infrared and ultrasound technology to detect veins, reconstructing vein images using 3D technology, and then using AI algorithms to intelligently analyze the images, selecting the most appropriate location and method for needle insertion to achieve automated intravenous puncture blood testing. The system typically integrates identity verification, medical order matching, catheter and needle supply, disinfection, pulse pressure, quantitative blood collection, catheter replacement, mixing, hemostasis, and traceability recording, forming an auditable closed-loop blood collection workflow. This aims to improve the success rate of first-time punctures, reduce pre-test errors, and alleviate the shortage of blood collection personnel. In 2025, the global production of blood collection robots was approximately 32 units, with a unit price of approximately US$97,800 and a gross profit margin of approximately 45%–65%.

Currently, blood collection still faces many challenges, with poor visibility and inaccurate punctures being the main issues. Infants' blood vessels are very thin, and those with thicker fat layers or darker skin tones often have blood vessels that are difficult to visually assess. The failure rate for first-time intravenous punctures in children is around 44%, and repeated punctures increase the psychological stress on nurses. Due to various factors, the efficiency of blood collection and testing in many hospitals is not high. During peak blood collection periods, the average waiting time for patients is 24 minutes, with over 64.5% of patients waiting more than 15 minutes. Even in commercial medical examination institutions, the average time for a "trial" blood collection exceeds 10 minutes. From a clinical perspective, many hospitals face the pain point of high blood collection pressure, creating a significant demand for blood collection robots. Furthermore, the long-term shortage of nursing staff has spurred the need for "substitute labor." Currently, automation solutions exist for queuing, blood collection tube sorting, blood diagnosis, and report output; only the blood collection process still relies on manual labor. Future machine replacement will complete the automated closed loop of blood diagnosis. From the perspective of practical applications in the medical field, blood collection robots are still in their early stages of development. Due to factors such as cost and hospital procurement processes, currently, most hospitals that can implement them are large tertiary hospitals. Companies in this sector are primarily focused on research and development; future commercialization may require more external CSOs (Contract Sales Organizations) to gradually penetrate hospitals. Globally, the European and American markets have significant potential, as nurses in these countries have lower success rates for manual intravenous punctures, making machine replacement a priority. However, cost reduction is a key factor for commercialization. Currently, blood collection robots entering the market are expensive. Significant commercial and social value will only be realized after technological iterations and their integration into primary healthcare systems.

This report delivers a comprehensive overview of the global Blood Collection Robots market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Collection Robots. The Blood Collection Robots market size, estimates, and forecasts are provided in terms of sales volume (Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Blood Collection Robots market comprehensively. Regional market sizes by Type, by Application, by Modules, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Blood Collection Robots manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Blood Collection Robots Market Report

Chapter Outline